Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

59.70
+0.11000.18%
Post-market: 59.50-0.2000-0.34%19:38 EDT
Volume:11.09M
Turnover:662.05M
Market Cap:121.53B
PE:13.14
High:60.10
Open:59.45
Low:59.01
Close:59.59
52wk High:68.64
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:0.84
T/O Rate:0.55%
Dividend:2.51
Dividend Rate:4.20%
EPS(TTM):4.54
EPS(LYR):3.46
ROE:46.60%
ROA:10.72%
PB:5.45
PE(LYR):17.25

Loading ...

Bristol Myers Squibb to Report Results for Third Quarter 2026 on October 29, 2026

THOMSON REUTERS
·
Sep 18

Bristol-Myers Squibb Announces R$ 2.15-Per-Unit Dividend for Q4 2026

Reuters
·
Sep 18

Bristol Myers Squibb Co. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 18

Bristol Myers Squibb Reports Sustained Sotyktu Responses in Psoriatic Arthritis Through 2 Years

MT Newswires Live
·
Sep 17

Bristol Myers Squibb Presents Sotyktu (Deucravacitinib) Data Showing Durable Efficacy, Consistent Safety in Adults with Psoriatic Arthritis over Two Years

THOMSON REUTERS
·
Sep 17

Bristol-Myers Squibb Company - Sotyktu Well-Tolerated Through Week 104 with no New Safety Signals

THOMSON REUTERS
·
Sep 17

Bristol-Myers Squibb Price Target Raised to $82.00/Share from $75.00 by Piper Sandler

Dow Jones
·
Sep 17

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Sep 16

Bristol-Myers Squibb (BMY) Receives a Buy from Piper Sandler

TIPRANKS
·
Sep 16

Bristol-Myers Squibb Keeps Quarterly Dividend at $0.63 a Share, Payable Nov. 2 to Shareholders of Record on Oct. 2

MT Newswires Live
·
Sep 16

Bristol Myers Squibb Announces Dividend

THOMSON REUTERS
·
Sep 16

Piper Sandler Adjusts PT on Bristol-Myers Squibb to $82 From $75, Keeps Overweight Rating

MT Newswires Live
·
Sep 16

Bristol Myers Sues Amgen over Proposed Opdivo Biosimilar

Reuters
·
Sep 16

RBC Capital Sticks to Their Hold Rating for Bristol-Myers Squibb (BMY)

TIPRANKS
·
Sep 15

BioMarin Appoints Bristol Myers Squibb Research Chief Robert Plenge to Board

Reuters
·
Sep 14

Press Release: BioMarin Announces Appointment of Robert Plenge, M.D., Ph.D., Chief Research Officer of Bristol Myers Squibb, to Board of Directors

Dow Jones
·
Sep 14

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Sep 14

Snowflake, Applied Materials, Dell, Zoom, Bristol-Myers Insider Shock

TIPRANKS
·
Sep 12

Top Bristol-Myers Squibb Executive Makes Major Move With Insider Stock Sale

TIPRANKS
·
Sep 11

RBC Capital Reaffirms Their Hold Rating on Bristol-Myers Squibb (BMY)

TIPRANKS
·
Sep 11